Patent · US Active

Medicinal concentrate of arbovirus specific immunoglobulins and F(ab)'2 and/or Fab fragments

US7771725B2 · kind B2 · utility

5Cited by

0References

23Claims

0Family size

Assignee

Laboratoire Francais du Fractionnement et des Biotechnologies · FR

Inventor

Roland Schmitthaeusler · Montigny-le-Bretonneux, FR

Key dates

Filing date	Apr 2, 2007
Grant date	Aug 10, 2010
Priority date	—
Expiry date	Apr 8, 2027

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention concerns a new medicinal product for the treatment of arboviruses, i.e.. a concentrate of immunoglobulins and F(ab)′2 and/or Fab fragments specific to said arbovirus as well as its process of preparation.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.